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Medication-related problems are common among home care 
patients who take many medications and have complex medical 
histories and health problems. The goals of home health care 
services are to help individuals to improve function and live with 
greater independence; to promote the client’s optimal level of 
well-being; and to assist the patient to remain at home, avoiding 
hospitalization or admission to long-term care institutions. Home 
care is an arrangement of care given by gifted experts to patients 
in their homes under the heading of a doctor. Home medicinal 
services administrations incorporate nursing care; physical, word 
related, and discourse dialect treatment; and therapeutic social 
administrations. Doctors may allude patients for home social in-
surance administrations, or the administrations might be asked 
for by relatives or patients. The scope of home social insurance 
benefits a patient can get at home is boundless. Contingent 
upon the individual patient’s circumstance, care can extend from 
nursing care to specific therapeutic administrations, for example, 
research facility workups. Normal analyses among home social 
insurance patients incorporate circulatory infection, coronary 
illness, damage and harming, musculoskeletal and connective 
tissue sickness and respiratory malady.
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ADR; Palliative Care; Elderly
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Figure 1. Patient Centered Medical Home Management. The American Academy of Family 
Physicians defines a medical home as one that is based on the Joint Principles of the Patient-
Centered Medical Home (PCMH), the Shared Principles of Primary Care, and the five key 
functions of advanced primary care. Through implementing medical home functions, practices 
seek to improve the quality, effectiveness, and efficiency of the care they deliver while responding 
to each patient’s unique needs and preferences. The American Academy of Pediatrics (AAP) 
introduced the medical home concept in 1967, initially referring to a central location for archiving a 
child’s medical record. In its 2002 policy statement, the AAP expanded the medical home concept 
to include these operational characteristics: accessible, continuous, comprehensive, family - 
centered, coordinated, compassionate, and culturally effective care. The American Academy of 
Family Physicians (AAFP) and the American College of Physicians (ACP) have since developed 
their own models for improving patient care called the “medical home” (AAFP, 2004) or “advanced 
medical home” (ACP, 2006) (Source: Cox JV, Kirschner N. Patient-centered medical home: 
Renewing Primary Care. J Oncol Pract. 2008 Nov;4(6):285-6. doi: 10.1200/JOP.0861501. 
PubMed PMID: 20856760; PubMed Central PMCID: PMC2793908). 
 
1. Introduction 
The scope of pharmacy services available in 
home-care continues to expand. Home care is 
a course of action of care given by talented 
specialists to patients in their homes under the 
heading of a specialist. Home restorative 
administrations organizations fuse nursing care; 
physical, word related, and talk lingo treatment; 
and remedial social organizations. Specialists 
may imply patients for home social protection 
organizations, or the organizations may be 
requested by relatives or patients. The extent of 
home social protection benefits a patient can 
get at home is unfathomable. Dependent upon 
the individual patient's condition, care can 
stretch out from nursing care to explicit 
remedial organizations, for instance, look into 
office workups. Typical investigations among 
home social protection patients join circulatory 
contamination, coronary disease, harm and 
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hurting, musculoskeletal and connective tissue 
affliction and respiratory ailment Patient-
centered communication is associated with 
increased patients’ satisfaction, better recall of 
information and improved health outcomes and 
requires active participation of both the 
pharmacist and the patient. Patients should be 
encouraged to express their needs and 
concerns regarding their medication, which 
pharmacists should address to support patients 
in making informed decision. Current 
viewpoints to consider in building up or 
assessing clinical pharmacy administrations 
offered in a home care setting include: staff 
competency, perfect target tolerant populace, 
staff security, utilization of innovation, 
community associations with other medicinal 
services suppliers, exercises performed amid a 
home visit, and pharmacist self-sufficiency. 
Picking up knowledge in the correspondence 
amid these home visits could be profitable for 
advancing these visits; and therefore, to 
enhance persistent well-being at readmission to 
essential care. A home visit convention 
empowers pharmacists:  
▪ To address known major challenges during 
the transition from hospital to primary care 
▪ To address patient’s dissatisfaction about 
health care is important as it facilitates 
patient participation during consultation and 
acceptance of pharmacists’ advices 
▪ To discuss patients’ medication beliefs and 
adherence issues more frequently, which 
might be facilitated by additional pharmacist 
training and increasing patient engagement 
2. Client Recruitment and Home Visits 
Upon admission to the office, any home care 
customer taking at least nine medications, 
including over-the-counter and herbal items, is 
offered a pharmacist home visit. Prior to the 
home visit, the pharmacist audits the 
customer's rundown of requested medications 
and graph notes from other home care 
clinicians, for example, attendants, word related 
therapists, and physical therapists. Amid the 
home visit, the pharmacist examines each drug, 
including over-the-counter items and herbal 
enhancements, with the customer and 
caregiver to evaluate their sign, adequacy, well-
being, and consistence, including 
reasonableness. After the main home visit, the 
pharmacist contacts the customer's prescriber 
with any suggestions for upgrading drug 
therapy. This correspondence is finished by 
electronic wellbeing record, phone, or fax. 
Basic proposals incorporate ceasing pointless 
or copy therapies or changing medicine 
portions. Follow-up care is composed by the 
pharmacist and nurse [1].  
2.1. Benefits of the Pharmacy Home Visit 
Program 
Although nurses and therapist, depending on 
client need and orders, assess all of a client's 
needs, the pharmacist is able to focus primarily 
on medications. Through the MOCH program, 
pharmacists and pharmacy technicians working 
with their health and social care colleagues and 
care homes staff, patients and their families, 
can provide a number of benefits for care 
homes and their residents including: 
▪ Optimizing medications (halting wrong or 
hazardous drugs, and guaranteeing meds 
increase the value of patient's wellbeing and 
prosperity)  
▪ Patient focused care (shared basic 
leadership about which drugs care home 
occupants take and stop)  
▪ Creating better medications frameworks for 
care homes to decrease waste and 
wastefulness  
▪ Training and supporting care home staff to 
improve more secure organization of drugs 
[2].  
▪ Available investigations have indicated 
diminished human services usage, 
diminished expenses to the wellbeing 
framework, and enhanced drug the 
executives with pharmacy inclusion in home 
care.  
▪ Beneficial persistent results of pharmacy 
practice in home care settings, for example, 
diminished medical clinic confirmations, 
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diminished crisis division visits, enhanced 
personal satisfaction, enhanced 
consistence, and diminished antagonistic 
occasions, have been depicted in many 
created nations.  
▪ Positive impacts of pharmacy practice in 
walking care settings, for example, 
diminished benzodiazepine use, enhanced 
nervousness scores, enhanced heart 
results, and enhanced consistence.  
▪ Most home care pharmacy programs in 
created nations give a few administrations, 
including extensive or focused taking drugs 
audits; training for patients, families, and 
staff; and arrangement of medication data 
[3]. 
 
 
 
Figure 2. The symptoms of a MRPs with the elderly patients. MRPs is the fourth leading cause 
of death in the elderly and can also cause disability, depression, gait disturbances, and falls. Some 
of the factors for increasing the risk of MRP in elderly are suboptimal prescribing (e.g. over use of 
medications, polypharmacy, inappropriate use, and under use), medication errors (both dispensing 
and administration problems), patient medication nonadherence (both intentional and 
unintentional), and multiple medications. These problems are considerably increase the cost of 
health care system. The adverse drug effects in the elderly population can be reduced and 
perhaps prevented by the physician anticipating the effects of drug toxicity and understanding how 
the patient's age and health status will likely affect drug dosing (Ramanath K, Nedumballi S. 
Assessment of medication-related problems in geriatric patients of a rural tertiary care hospital. J 
Young Pharm. 2012;4(4):273-8). 
 
2.2. Common MRPs and Success of 
Pharmacy Visits at Home 
Traditionally, nursing homes have been 
associated with suboptimal drug therapy and 
MRPs. In contrast, less is known about drug 
safety in homecare. Significantly more MRPs 
were detected among patients receiving home 
nursing care than patients living in nursing 
homes. While patients living in nursing homes 
were often undermedicated, documentation 
discrepancies were more frequent in home-
nursing care. MRP categories leading to 
changes on the medication lists differed 
between the settings. 
▪ Untreated conditions: The patient has a 
medical condition that requires drug therapy 
but is not receiving a drug for that condition. 
▪ Drug use without indication: The patient is 
taking a medication for no medically valid 
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condition or reason. For example, a client 
may be taking proton-pump inhibitor 
although he or she does not have a history 
of gastroesophageal reflux disease or peptic 
ulcers. Conversely, a client with 
hypertension and diabetes mellitus may not 
be taking aspirin, although he or she has an 
indication for it. 
▪ Improper sedate determination: The 
patient's medical condition is being treated 
with the wrong medication or a medication 
that isn't the most fitting for the patient's 
uncommon needs.  
▪ Subtherapeutic measurements: The patient 
has a medical issue that is being treated 
with excessively little of the right 
prescription.  
▪ Overdosage: The patient has a medical 
issue that is being treated with a lot of the 
right prescription.  
▪ Effectiveness: Effectiveness-related issues 
happen when a medicine portion is 
excessively low or when a progressively 
compelling medication is accessible. For 
instance, a patient with unending torment 
might take acetaminophen when a narcotic 
might be progressively successful.  
▪ ADRs: The patient has a medical condition 
that is the aftereffect of an unfriendly 
medication response or unfavorable impact. 
On account of more established grown-ups, 
unfavorable medication responses add to 
officially existing geriatric issues, for 
example, falls, urinary incontinence, 
clogging, and weight reduction.  
▪ Safety: When a customer is taking a 
medicine with a portion that is excessively 
high or is taking a prescription that causes 
an unfriendly medication response, the 
person in question is encountering a 
security drug related issue. For instance, a 
customer will be unable to take amitriptyline 
for a sleeping disorder since anticholinergic 
symptoms are excessively troublesome.  
▪ Drug connections: The patient has a 
medical condition that is the aftereffect of a 
medication cooperating adversely with 
another medication, nourishment, or 
research center test.  
▪ Compliance: The patient has a medical 
condition that is the aftereffect of not getting 
a prescription because of monetary, mental, 
sociological, or pharmaceutical reasons. 
Compliance-related problems describe 
instances when a client prefers not to take a 
medication, does not understand how to use 
a medication, or cannot afford a medication. 
A client is experiencing a compliance-
related problem if he or she does not 
understand how to use an inhaler or prefers 
not to take a medication to treat a condition 
[1], [4], [5]. 
▪ The core of the PATCH service is the ability 
of pharmacists to provide comprehensive 
patient-centered care by identifying MRPs 
and making evidence-based 
recommendations to providers to optimize 
medication use. MRPs have been estimated 
to cost approximately $177.4 billion per year 
and are estimated to be one of the top 5 
causes of death in the elderly population. 
Identifying, resolving, and preventing MRPs 
can lead to cost savings as well as 
improved patient outcomes [6]. Traditionally, 
the availability of clinical pharmacy services 
has been in the purview of hospitals where 
increased clinical pharmacy services has 
been associated with reduced length of stay 
and mortality. Acknowledgment of the 
estimation of the job of the pharmacist has 
brought about development of clinical 
administrations into outpatient settings, 
including quiet homes. For instance, the 
HMR program that was built up in Australia 
in 2001 gives financing to pharmacists to 
visit patients at home to survey their drug 
regimens. In Canada, commonplace 
governments are repaying pharmacists for 
giving prescription audits (MRs) for non-
hospitalized patients and furthermore 
approving pharmacists to endorse [7]. 
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Figure 3. Pharmacist involvement in Post-discharge warfarin management. In the post-
discharge setting, a RCT of home visits and point-of-care (POC) INR testing by a pharmacist 
improved the initiation of warfarin therapy and resulted in a significant decrease in hemorrhagic 
complications in the first 3 months of therapy. The objective of this trial is to develop and 
implement a sustainable program to enable the smooth transition of both newly anticoagulated 
patients and those already taking warfarin from the hospital to community setting. An HMR 
involves the patient, after referral by their GP, being visited at home by an ‘accredited’ pharmacist 
who reviews their medication regimen, delivers education and provides the GP with a report and 
management suggestions. The GP and patient then agree on a medication management plan. 
The process is facilitated by the patient’s regular community pharmacist, which further assists in 
the development of cooperative working relationships between the members of the patient’s 
healthcare team. Based on the excellent results of the previously trial program, this service has 
been proposed as a potential solution to many of the issues faced in the post-discharge period by 
patients taking warfarin. The aim is to incorporate POC INR monitoring and warfarin education into 
the existing HMR remuneration structure to produce a streamlined and sustainable model more 
pragmatic for widespread implementation into practice (Source: Stafford et al.: A role for 
pharmacists in community-based post-discharge warfarin management: protocol for the ‘the role of 
community pharmacy in post hospital management of patients initiated on warfarin’ study. BMC 
Health Services Research 2011 11:16. doi:10.1186/1472-6963-11-16). 
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Figure 4. The Pharmacist Advancement of Transitions of Care to Home (PATCH) model, 
developed by CDC in 1983. PATCH was created for application among diverse partners at the 
local level, but also within the context of vertical collaboration within the governmental public 
health infrastructure (federal, state, and local levels) and horizontal collaborations with voluntary 
organizations, academia, and other partners at all levels. PATCH has five critical elements or 
phases. (1) community member participation, (2) data-based program development, (3) 
collaborative development of a comprehensive health promotion strategy, (4) evaluation for 
feedback and improvement, and (5) the enhancement of community capacity for health promotion. 
Although PATCH encourages the active engagement of local governmental health agencies, it 
recognizes that these may not always be the “most appropriate and/or effective focal point for 
PATCH” and “primary care clinics, university groups, businesses, and other nongovernmental 
organizations may be in a better position to exercise leadership for a PATCH program” with the 
support and facilitation of the local health agency. The implementation of PATCH highlighted 
several elements that seem to be associated with successful community-based public health 
planning and action. These include the existence of a core of community support and participation, 
data collection and analysis, setting of objectives and standards to help with planning and 
evaluation, the adoption of multiple strategies on multiple fronts, sustained monitoring and 
progress evaluation to fine-tune projects, and the support of the governmental public health 
infrastructure nationally and locally (Institute of Medicine (US) Committee on Assuring the Health 
of the Public in the 21st Century. The Future of the Public's Health in the 21st Century. 
Washington (DC): National Academies Press (US); 2002. B, Models for Collaborative Planning in 
Communities. Available from: https://www.ncbi.nlm.nih.gov/books/NBK221247/) 
 
3. Residential Care Pharmacists into Aged 
Care Homes 
Endorsing in the private matured care populace 
is perplexing, and requires continuous survey to 
avert medicine misfortune. Coordinating an on 
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location clinical pharmacist into private care 
groups is an unexplored chance to enhance 
quality utilization of drugs in this setting. 
Pharmacist-drove drug audit is viable in 
decreasing prescription related issues; be that 
as it may, current financing plans explicitly bar 
pharmacists from routinely taking an interest in 
inhabitant care [8]. 
 
 
Figure 5. Pharmacovigilance in Polypharmacy issues in elderly. The Slone Survey reported 
that 60% and approximately 20% of elderly patients in the US receive more than five and 10 or 
more medicines, respectively. Consequently, polypharmacy is common among the elderly. 
Polypharmacy is related to increased risk of being administered PIM. Other PIM criteria including 
STOPP/START have been used. These criteria are suitable for determining the appropriateness of 
prescriptions. The STOPP and START tools identify inappropriate medications in elderly, including 
drug-drug and drug-disease interactions, drugs that increase the risk of falls, and drugs that 
duplicate therapy. The Beers and STOPP tools are used to address over- and misuse of 
medications. The START tool allows the detection of potentially inappropriate drug omissions 
(Source: Abe J, Umetsu R, Uranishi H, et al. Analysis of polypharmacy effects in older patients 
using Japanese Adverse Drug Event Report database. PLoS One. 2017;12(12):e0190102. 
Published 2017 Dec 21. doi:10.1371/journal.pone.0190102).  
 
3.1. Medication Use in Older Adults 
Prescribing in the older population is highly 
complex. Age-related pharmacokinetic and 
pharmacodynamic changes lead to variations in 
drug bioavailability, increased drug sensitivity, 
and decreased regulatory mechanisms, altering 
the effects of drug usage from those observed 
in younger populations. In addition, the 
presence of multiple co-morbidities 
necessitating multiple medication usage 
equates to an increased risk of medication 
misadventure in older adults. Advancing age is 
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positively correlated with increased prevalence 
of chronic disease, and increased number of 
co-morbidities correlates with increased 
medication use [9-13]. ADEs can significantly 
impair occupational and cognitive functioning, 
and quality of life. All medications have the 
potential to cause an ADE, particularly in older 
adults, as a result of pathophysiological decline, 
inappropriate polypharmacy, and involvement 
of multiple health providers. This can worsen 
cognitive impairment, frailty, disability, 
frequency of falls, and mortality [12,13].  
 
 
Figure 6. The SIMPATHY (Stimulating Innovation Management of Polypharmacy and Adherence 
in The Elderly) Project. Inappropriate polypharmacy increases the likelihood of adverse drug 
events, drug interactions and non-adherence. Areas covered: A detailed description of a pan-
European initiative, 'Stimulating Innovation Management of Polypharmacy and Adherence in the 
Elderly, SIMPATHY', which is a project funded by the European Commission to support innovation 
across the European Union. This includes a systematic review of the literature aiming to 
summarize and review critically current policies and guidelines on polypharmacy management in 
older people. The policy driven, evidence-based approach to managing inappropriate 
polypharmacy in Scotland is described, with consideration of a change management strategy 
based on Kotter's eight step process for leading sustainable change. Expert opinion: The 
challenges around promoting appropriate polypharmacy are on many levels, primarily clinical, 
organizational and political, all of which any workable solution will need to address (Source: 
Stewart D, Mair A, Wilson M, Kardas P, Lewek P, Alonso A, McIntosh J, MacLure  K; SIMPATHY 
consortium. Guidance to manage inappropriate polypharmacy in older people: systematic review 
and future developments. Expert Opin Drug Saf. 2017 Feb;16(2):203-213. doi: 
10.1080/14740338.2017.1265503. Epub 2016 Dec 4. Review. PubMed PMID: 27885844). 
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3.2. Transitions of Care and ADEs 
Changing into matured care has been 
recognized as an especially high-chance point 
where inhabitants are defenseless against drug 
mistakes and ADEs. Advances of care for 
occupants incorporate new affirmation from the 
network or medical clinic to a RACH, or coming 
back to the RACH post-release from 
emergency clinic. Clumsy care advances and 
miscommunication can result in intruded on 
coherence of care and unfriendly occasions, 
which may prompt improper re-admission to 
medical clinic or introduction to crisis offices. A 
study shows Hypertension (nearly 50%%) was 
the highest prevalent chronic disease among 
the study participants followed by osteoarthritis 
(35%), diabetes mellitus (more than 25%), 
respiratory disorders (14%) and cerebro-
vascular accidents (11%) in old-age homes of 
Malaysia. Roughly 20% of inhabitants 
encounter a noteworthy postponement in drug 
organization and missed dosages following 
affirmation or re-admission to a RACH. Change 
related prescription blunders are seen in 13– 
31% of RACH inhabitants, frequently include 
high hazard drugs, for example, warfarin, 
insulin, psychoactive operators, and narcotics, 
and have more serious danger of making 
genuine damage the occupant [14-17]. 
 
 
 
Figure 7. Schema of the medicine reconciliation process at admission and discharge. This 
includes all prescribed medicines, nonprescription and OTC products. It is an opportunity to 
discuss with the patients their adherence, including questioning if they have any swallowing 
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difficulties or issues such as being unable to open containers or remove the tablets from the 
blisters, and if they are experiencing any adverse effects from their medicines, which may be 
affecting their adherence. Research has shown that for patients in hospital, a quarter of 
medication errors can be directly attributed to reconciliation of medications taken prior to 
admission not being completed. An unintentional change to regular medications is considered a 
discrepancy as is an intentional change that has not been documented in the patient medical 
record. Every patient should have their medications reconciled on admission by a pharmacist, but 
often in the hospital setting, due to the pressure on pharmacy resources, a prioritization system is 
required to reconcile patients who are considered to be at higher risk for medication errors 
(Nicholls J, MacKenzie C, Braund R. Preventing drug-related adverse events following hospital 
discharge: the role of the pharmacist. Integr Pharm Res Pract. 2017;6:61-69. Published 2017 Feb 
13. doi:10.2147/IPRP.S104639). 
 
3.3.  Communicable Disease Prevention 
Five most common infections in the elderly are 
UTIs, GI infections, Bacterial pneumonia and 
influenza. Viral infections like herpes zoster 
(shingles), pressure ulcers, bacterial or fungal 
foot infections (which can be more common in 
those with diabetes), cellulitis, drug-resistant 
infections like MRSA are common skin 
infections. More than 60% of seniors over 65 
get admitted to hospitals due to pneumonia, 
reported by AAFP (underlying causes are 
changes in lung capacity, increased exposure 
to disease in community settings, and 
increased susceptibility due to other conditions 
like cardiopulmonary disease or diabetes). 
Influenza and pneumonia combined add up to 
the sixth leading cause of death in America — 
90% of these in senior adults. Weakened 
immunity in the elderly, along with other chronic 
conditions, increases the risk of developing 
severe complications from influenza, such as 
pneumonia. Because influenza is easily 
transmitted by coughing and sneezing, the risk 
of infection increases in a closed environment 
like a nursing home. Cough, chills and fever are 
the common symptoms, though, again, 
influenza may present different signs in older 
adults. Influenza is generally preventable 
through yearly inoculation, and there is 
adequate proof to help RACH staff 
immunization to shield inhabitants from flu. The 
reasonable for this is to enhance openness to 
the inoculation for individuals from the network 
who experience issues getting to the antibody 
through their GP or business, as drug stores 
are regularly open later and on ends of the 
week [18-21].  
4. Terminal/Palliative Care 
Palliative care in U.S. hospitals increasing 
every year, according 2018 Palliative Care 
Growth Snapshot issued by the CAPC. The 
predominance of medical clinics (at least 50 
beds) with a palliative care group expanded 
from 658 to 1,831– a 178% expansion from 
2000 to 2016 [22]. Also, By 2056, 480,000 
Canadian deaths for every year are anticipated 
with 90% of those deaths being qualified for 
palliative care [23]. Patients determined to have 
a terminal ailment regularly require 
nonstandard portions that are not accessible 
financially, so pharmacists thinking about 
hospice patients may need to compound items 
to meet individual patients' one of a kind needs 
[24,25]. This may incorporate planning 
arrangements that are seasoned to conquer 
unfortunate qualities or delivering measurement 
shapes with elective fixings as well as 
excipients to maintain a strategic distance from 
hypersensitive responses or dynamic 
prejudices. Pharmacists can frequently suggest 
dosing gadgets that assistance patients and 
caregivers convey the correct portion of 
exceedingly powerful drugs. Such gadgets may 
not generally be promptly accessible to patients 
in the network.  
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4.1. Medication Dispensing for 
Terminal/Palliative Care 
Most palliative pain medications are controlled 
substances and are registered among the most 
highly controlled Schedule II drugs. IAHPC 
identified 21 symptoms and included 33 
essential medications for control of these 
symptoms. In addition, according to a recent 
study based on international expert consensus 
opinion, four essential drugs were used for 
alleviation of anxiety, dyspnea, nausea and 
vomiting, pain, and respiratory tract secretions, 
as well as terminal restlessness. These include 
morphine, midazolam, haloperidol, and an 
antimuscarinic, which should be offered in the 
last 48 hours of life for patients with cancer 
[26,27]. Futile medication use in management 
of terminally ill cancer patients has also been 
reported, one-fifth of cancer patients at the end 
of their life took futile medications. Statins met 
futility criteria in 97% of cases, gastric 
protectors in 50%, antihypertensive agents in 
27%, antidiabetic prescriptions in 1%, 
bisphosphonates in 26%, and antidementia 
drugs in 100% of patients.  Unlike 
chemotherapy, there is no framework in place 
to validate halting radiation therapy either in the 
name of overutilization or futility [28,29]. 
4.2.  Non-Traditional Administration 
Routes 
Elective organization courses for palliative care 
are crucial to giving viable patient care. 
Numerous regularly endorsed medications (eg, 
promethazine, morphine sulfate) might be 
utilized in nontraditional courses [30]. Topical 
gels containing metoclopramide, 
diphenhydramine or lorazepam may found 
worthful for patients with unmanageable 
sickness and spewing [31,32]. Usually 
recommended drugs can have nontraditional 
utilizations and rectal bioavailability, for 
example, 
carbamazepine/Topiramate/Lamotrigine tablets 
or suspension for spasms; rectal use may 
permit fast ingestion and halfway maintain a 
strategic distance from first-pass digestion 
because of rectal venous deplete [33]. In the 
event that essential, medications can be 
intensified into parenterals, arrangements, 
creams, balms, and transdermal measurements 
details to enhance quiet adherence and 
improve AEs, for example, stoppage, 
queasiness, gastrointestinal issues, and 
sedation [34]. Different measurement frames, 
including transdermal patches of scopolamine 
and terminal infusions of octreotide, are utilized 
to treat explicit requirements of individual 
patients [35].  
 
Exhibit 1. Alternate routes to oral opioid administration [74] 
Route Advantage Disadvantage 
Intravenous Widely used and accepted by clinicians 
and patients 
May have limited availability, especially in 
home/nursing home settings 
Enteral Morphine is compatible with enteral 
feedings at temperatures from 22 to 
50°C 
Enteral drug practices vary widely leading to 
frequent medication errors, including crushing 
sustained-release tablets and failure to flush the 
tube before administering medication 
Subcutaneous Flexible, results in morphine levels 
equivalent to IV route, availability of SC 
access sites is virtually unlimited 
SC route should be avoided or used with 
caution in immunocompromised patients and in 
those patients with bleeding disorders 
Transdermal 
patches 
Ease of administration Local irritation can occur at patch site 
Intranasal 
(excluding nebulized 
medications) 
Convenient, rapid onset of action, no 
hepatic first-pass metabolism 
Nasal congestion and local irritation, URIs, 
change in naso-ciliary function 
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Sublingual Simplicity, rapid onset of action for highly 
lipophilic drugs (e.g., fentanyl and 
methadone) 
Hydrophilic drugs such as morphine and 
hydrocodone are poorly absorbed sublingually, 
bitter taste and burning sensation possible 
Buccal Simplicity, rapid onset of action for highly 
lipophilic drugs (e.g., fentanyl and 
methadone) 
High unit price may make branded formulations 
prohibitively expensive in capitated 
reimbursement systems (e.g., hospice) 
Rectal Simplicity, useful in patients with nausea 
and vomiting or those with dysphagia, GI 
obstruction, malabsorption, or impaired 
neuromuscular function 
Bioavailability can be affected by multiple 
factors, including the small surface area of the 
rectum, insufficient fluid to dissolve tablets or 
capsules, and presence of feces that can limit 
absorption 
  
4.3. Gastrointestinal Issues 
Gastrointestinal issues may develop secondary 
to many chronic conditions (eg, advanced 
cancer, neurologic disorders) [36]. Constipation 
is a standout amongst the most well-known 
issues patients involvement with the finish of 
life. The reason can be as straightforward as 
dietary modifications or the powerlessness to 
ambulate or work out. Extreme inconvenience 
and torment from stoppage may course into a 
persistent decrease in a patient's personal 
satisfaction, requiring pharmacologic mediation. 
Security issues amid toileting and the 
powerlessness to finish poop without help may 
advance as a perpetual sickness declines, with 
the extent of individuals with extreme issues 
expanding as death approaches [37]. 
Pharmacists can have a vital impact in 
anticipating and dealing with the side effects of 
blockage, for example, entrail check, drying out, 
loss of craving, versatility issues, and drug AEs. 
Numerous non-pharmacologic methodologies 
(e.g, dietary changes, evasion of negative 
natural boosts, conduct estimates, for example, 
unwinding) may help patients without adding to 
the pharmacologic weight [38]. 
4.4. Individualized Care or PCC 
The point of palliative care is to enhance the 
personal satisfaction of patients and families 
through the anticipation and help of anguish. 
Palliative care in the home is the arrangement 
of specific palliative consideration in the 
patient's home, regularly given by attendants as 
well as doctors with or without association with 
a doctor's facility or hospice. In a study of 1200 
Canadians, more prominent than 70% of 
respondents wanted to be at home close 
demise [39]. Since palliative consideration 
regimens are very individualized to address 
every patient's issues, coordinating a 
pharmacist into the interdisciplinary group is 
fundamental to accomplishing a patient's 
consideration objectives. Body energy and 
volume of circulation are changed in patients in 
end-of-life care.  
4.5. Role of The Caregivers 
Home care clinicians in the WRHA currently 
rely on community pharmacists for assistance 
with medication-related issues. According to 
NCCN “Palliative care specialists and 
interdisciplinary palliative care teams, including 
board-certified palliative care physicians, 
advanced practice nurses, and physician 
assistants, should be readily available to 
provide consultative or direct care to 
patients/families who request or require their 
expertise,” [40]. Pharmacists have an 
exceptional learning base for improving patient 
consideration while diminishing AEs and toxicity 
[23], [41]. Palliative care utilizes a group 
approach, including doctors, medical 
attendants, social laborers, pastors, and 
pharmacists. The pharmacist's job inside 
palliative care groups is expanding and 
introductory great results have been accounted 
for. Investigation of patients with known date of 
first pharmacist visit found altogether enhanced 
LOS, LTC, and CTD for patients with early 
access to palliative pharmacy (notwithstanding 
alternate individuals from the palliative group) 
contrasted with those without early access [42]. 
Network drug stores are recommended to 
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consider stocking the five "fundamental" 
palliative care drugs: clonazepam 1mg/ml, 
morphine 10mg/ml, haloperidol 5mg/ml, 
metoclopramide 10mg/2ml, and Hyoscine 
butylbromide 20mg/ml [43,44]. Know About 
Caring for Children According to the Picker 
Institute and Harvard Medical School has 
delineated following dimensions of patient-
centered care, including:  
▪ Respect for the patient's values, 
preferences, and expressed needs  
▪ Information and education  
▪ Access to care  
▪ Emotional support to relieve fear and 
anxiety  
▪ Involvement of family and friends  
▪ Continuity and secure transition between 
health care settings  
▪ Physical comfort 
▪ Coordination of care [45] 
  
Exhibit 2. Goals of care for patients in the dying phase * 
Comfort 
measures 
▪ Current medication assessed and non-essentials discontinued 
▪ As required subcutaneous drugs written up according to protocol (pain, agitation, 
respiratory tract secretions, nausea, vomiting) 
▪ Discontinue inappropriate interventions (blood tests, antibiotics, intravenous fluids or 
drugs, turning regimens, vital signs); document not for cardiopulmonary resuscitation 
Psychological 
and insight 
issues 
▪ Ability to communicate in English assessed as adequate (translator not needed) 
▪ Insight into condition assessed 
Religious and 
spiritual support 
▪ Religious and spiritual needs assessed with patient and family 
▪ Communication with family or others 
▪ Identify how family or other people involved are to be informed of patient's impending 
death 
▪ Family or other people involved given relevant hospital information 
Communication 
with primary 
healthcare team 
▪ General practitioner is aware of patient's condition 
▪ Plan of care explained and discussed with patient and family 
▪ Family or other people involved express understanding of plan of care 
* Adapted from the Liverpool care pathway for the dying patient—initial assessment 
 
4.6.  Clinicians Involved in PPC 
Palliative care clinicians are also called to 
assist with pediatric-aged patients. The PPC 
team includes multiple disciplines, community-
based resources, and family members.  Due to 
advancing technology and medical expertise, 
children are living longer and with greater 
medical complexities. Accurate prognostication 
in pediatrics is complicated by the lack of 
empirical research and heterogeneous medical 
experiences. Understanding a family’s narrative 
about their child’s illness and their definition of 
quality of life is essential for effective goals of 
care discussions. Children are not small adults. 
Developmental differences among infants, 
children, and adolescents that affect diagnosis, 
prognosis, treatment strategies, 
communication, and decision-making 
processes present challenges to adult providers 
who do not have training or experience in 
caring for children. Most symptoms for pediatric 
patients can be managed analogous to that of 
adult patients; however, complex neurologic 
symptoms and feeding difficulties are prevalent 
and distinct in pediatric population. Families of 
pediatric patients often choose to accept the 
burdens involved in the use of life-sustaining 
technology for the benefit of a longer life for 
their child. Children develop increasing 
decision-making capacities as they get older 
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and should have increasing roles in healthcare 
decisions. Their understanding of illness and 
death evolves over time [46,47]. NHPCO’s 
Quality Partners program utilizes the Standards 
of Practice as its foundation to provide a 
framework for quality assessment and 
performance improvement. 
5. Transition of Care: Issue of Collaboration  
Improving medication management during care 
transitions will require 3 main initiatives. First, 
the patient must remain the central focus of 
care. Second, interprofessional communication 
and collaboration need to occur among all 
providers involved in the health care of 
individual patients. Third, the outcomes of 
pharmacist involvement during care transitions 
needs to be evaluated systematically (ideally in 
controlled trials) to demonstrate a cost-effective 
improvement in quality and to provide financial 
justification for investing in pharmacist 
resources. Collaboration between hospital and 
community pharmacists can also facilitate 
patient-centered care. Multiple medication 
changes during hospitalization can be 
confusing to patients, caregivers, and 
providers, and can lead to medication errors. 
Hospital pharmacists can provide a reconciled 
medication list and meet with patients for 
counseling and education. Typically, the day of 
discharge is busy, and patients have limited 
time and attention to discuss important issues. 
A “hand-off” or pharmacist discharge care plan 
could facilitate the coordination of medication 
management between the hospital and 
community pharmacist. This provides continuity 
so that the community pharmacist has a list of 
actual or potential medication-related problems 
to follow-up on with the patient or other health 
care providers. It also provides the community 
pharmacist with patient information that they 
would not normally have access to [48]. 
Resources should be targeted toward patient 
populations at increased risk for readmission, 
such as patients with heart failure, COPD, 
asthma, advanced age (discussed earlier), low 
health literacy, and frequent hospitalizations 
(FEs). 
5.1. Heart Failure Management 
Network pharmacists who grow their jobs and 
make home visits to heart disappointment (HF) 
patients after medical clinic release can 
enhance results. Home human services groups 
once in a while incorporate pharmacists when 
they give care to patients experiencing 
advances in care. HF influences roughly 6 
million grown-ups in the USA, with more than 
$30 billion in related yearly expenses; by 2030, 
these figures are required to ascend to in 
excess of 8 million grown-ups and more than 
$69 billion. From 2012 to 2014, the age-
balanced rate of HF-related deaths per 100,000 
individuals expanded from 81.4 to 84.0. The 
effect of pharmacist intercession was assessed 
in a pharmacy-drove TOC program for patients 
with HF from a US clinic. The objective of TOC 
is to help as of late released patients keep 
away from pointless medical clinic and crisis 
room re-affirmations while guaranteeing speedy 
mending and recuperation comfortable. Their 
primary functions are in-home medical care, 
collaboration and communication with patient’s 
primary care provider, specialist and 
discharging hospital, discharge summary 
review, lab testing & diagnostic imaging, 
medication reconciliation & adherence etc. 
Admission medication reconciliation and 
discharge medication review were performed to 
monitor for appropriateness and dosing, 
duplications, omissions, and drug interactions. 
Pharmacy-led TOC increased compliance with 
HF core measures (including appropriate 
medication use) and reduced HF readmissions, 
30-day readmissions, all-cause readmissions, 
and costs [49-51]. 
 
Exhibit 3. SIMPLE approach to identify compliance barriers during discharge and to improve adherence [50] 
S Simplify the regimen 
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I Impart Knowledge 
M Modify patients believe and behavior 
P Provide communication and trust 
L Leave the bias 
E Evaluate the adherence 
 
5.2. COPD Management 
COPD, the fourth leading cause of death 
worldwide, is also a major cause of chronic 
morbidity all over the world, particularly in 
developing countries. In 2016, it was the third 
leading cause of years of life lost and disability-
adjusted life-years in the United States, with an 
estimated 164 000 deaths. Indeed, in 2012, 
more than 3 million people worldwide died of 
COPD, equating to 6% of all deaths globally in 
that year. In the UK, the costs associated with 
COPD are estimated to exceed £800 million. In 
the USA, more than 26 million people are 
estimated to have COPD but almost half of 
these are undiagnosed. The significance of 
effective COPD exacerbation management is 
critical to managing healthcare resources.  
Clinical improvement depends on many factors 
such as drug selection, patient compliance and 
control of other risk factors including the 
environment and nutrition. Patients at risk for 
having an exacerbation of COPD should 
receive self-management strategies. Prompt 
therapy prior to exacerbations reduces hospital 
admissions and readmissions, speeds 
recovery, and slows disease progression. 
COPD patients tend to have better medication 
adherence with pharmacist counseling, 
subsequently improving their quality of life as 
well as clinical outcomes. Direct education by 
pharmacists has been shown to be more 
effective than other teaching methods, including 
watching videos and providing inhaler 
pamphlets. With increasing number of COPD 
patients, individualized counseling for patients 
is a challenge to the limited number of 
physicians. Incorrect use of inhalers is very 
common and subsequently leads to poor 
control of COPD. Pharmacist-led 
comprehensive inhaler technique intervention 
program using an unbiased and simple scoring 
system can significantly improve the inhaler 
techniques in COPD patients. A 3-month 
combined program of transition and long-term 
self-management support resulted in 
significantly fewer COPD-related 
hospitalizations and emergency department 
visits and better HRQL at 6 months after 
discharge [52-58]. 
 
Exhibit 4. Frequent Hospitalization and Risk of AECOPD [59] 
Frequent exacerbations (FEs) imply that the illness is advancing quicker, expanding the danger of intense re-
compounding and mortality. Late investigations demonstrated that ≥2 occasions/year of AECOPD or ≥1 
occasion/year of AECOPD prompting hospitalization was the hazard factor for future worsening occasions. The 
COPDGene think about demonstrated that divider thickness and emphysema were engaged with AECOPD and were 
free of wind current confinement. Among others, divider thickness and EI, two imaging highlights, are very much 
acknowledged pointers mirroring the obsessive changes of COPD. Exacerbation hospitalizations in the past year and 
EI were independently associated with hospitalization. A cohort study shows that with the increase in the number of 
hospitalizations, the risk of acute exacerbation and death increased in turn.  
 
5.3. Hip/Knee Arthoplasty 
THA and TKA, collectively known as TJA, are 
beneficial and cost-effective procedures for 
patients with symptomatic osteoarthritis. The 
US health care system is the costliest in the 
world – accounting for 17% of GDP – estimates 
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that percentage will grow to nearly 20% by 
2020. TJA is the single largest cost in 
Medicare, with reports showing a $13.43 billion 
annual price tag for THAs, and a $40.8 billion 
annual price tag for TKAs. 20% of readmissions 
occur due to a medication error, 60 % of all 
medication errors occur during times of care 
transitions. The most common cause of 
unplanned readmission at both 30 and 90 days 
post-THA were joint-specific reasons, including 
dislocation and joint malfunction. The second 
and third most common causes for unplanned 
readmission, again at both 30 and 90 days, 
were surgical sequelae and thromboembolic 
disease, followed by surgical site infection. the 
pharmacologic intervention directly related to 
the procedure post-surgery is often limited to 
pain management (most commonly opioid 
analgesics).  Unlike chronic disease 
management, the effect of proper pain 
manages - mint tends to be more tangible to 
the patient. When non-adherent to the pain 
management regimen, the resulting symptoms 
tend to be incentive enough for the patient to 
become adherent until the operative pain is 
resolved permanently [60-64]. 
5.4. Transitional Care Needs of LHL in 
Hospitalization 
Hospitalization represents a crucial care 
transition point for patients with exacerbations 
of chronic disease, in which patient education 
can aid in improving disease management and 
reducing negative health outcomes after 
discharge, such as readmissions and discharge 
medication errors. Resources may be limited 
for in-hospital patient education, so triaging by 
HL level may be necessary for resource-
optimization. LHL affects approximately 30% to 
60% of adults in the US, Canada, Australia, and 
the EU. Screening for inadequate health 
literacy and associated needs may enable 
hospitals to address these barriers and improve 
post-discharge outcomes. Health literacy is 
associated with many factors that may affect 
successful navigation of care transitions, 
including doctor-patient communication, 
understanding of the medication regimen, and 
self-management). Research has also 
demonstrated an association between low 
health literacy and poor outcomes after hospital 
discharge (misunderstanding discharge 
instructions, poor self-rated health, self-efficacy, 
and decreased use of preventative services), 
including medication errors, 30-day hospital 
readmission, and mortality. Potential ADEs are 
also common and arise from unintentional 
discrepancies between admission and 
discharge regimens, such as changes in dose, 
route, or frequency, and/or introduction of new 
medications. Transitional care initiatives have 
begun to incorporate health literacy into patient 
risk assessments and provide specific attention 
to low health literacy in interventions to reduce 
adverse drug events and readmission. Patients 
– particularly those with limited health literacy – 
found a hospital pharmacist-based intervention 
to be very helpful and empowering. The PILL-
CVD study consisting of pharmacist-assisted 
medication reconciliation, inpatient pharmacist 
counseling, low-literacy adherence aids, and 
individualized telephone follow-up, on the 
number of clinically important medication errors 
after hospital discharge suggested more 
involvement of pharmacists and opportunities 
for better outcome [65-69]. 
5.5. Prevention of Hospital Readmissions 
Most common cases of hospital readmissions 
in US are heart failure, heart attack, and 
pneumonia, hip and knee replacements, 
exacerbations of COPD; heart bypass. The 
penalties were capped at 1% of Medicare 
reimbursements in 2013, 2% in 2014, and 3% 
in 2015. The administration assesses that the 
punishments for financial year 2015 will add up 
to $424 million and influence 2,638 emergency 
clinics, speaking to a normal punishment of 
more than $160,000 per medical clinic. About 
20% more established grown-ups are 
readmitted to a medical clinic inside 30 days of 
release. Given that the greater part of these 
readmissions is preventable, the new 
punishments are convincing emergency clinics 
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to make the decrease of readmissions a need. 
The people group contact pharmacist gives the 
missing connection between clinic care and the 
home, just as among various human services 
suppliers, in this manner limiting admission to 
the emergency clinic because of medicine 
blunder and advancing proper portion of social 
insurance assets. Also, people group 
pharmacists, the medicinal services experts 
who have the most collaboration with patients' 
post-release, are frequently underutilized. 
Being an indispensable piece of the change of-
care process, pharmacists can demonstrate 
their incentive as well as push the pharmacy 
calling toward being perceived as containing 
social insurance suppliers. Network contact 
programs obviously help lessen medical clinic 
readmissions and different sorts of mischief and 
squandered assets related with preventable 
unfavorable medication occasions. [69-72].
 
 
Figure 8. The Health Literacy Pathway Model. The model includes five stages along a pathway; 
each stage requires a more complex set of health literacy abilities. As participants progress 
through each stage, they develop their health literacy further and gain the opportunity to feel more 
empowered. Health literacy processes are represented in the five stages of the Pathway Model 
and health literacy outcomes are represented as running parallel to those stages. Longitudinal 
qualitative analysis of how participants' developed and used their health literacy skills to become 
more active and empowered patients enabled us to map a set of stages that participants 
progressed through as they increased their knowledge and understanding of their condition, 
learned how to manage it, actively participate in discussions with health professionals, and make 
informed self-management and treatment decisions. Progression through these stages is 
presented in a theoretical model mapping a health literacy pathway from health knowledge 
towards decision-making (Source: Edwards M, Wood F, Davies M, Edwards A. The development 
of health literacy in patients with a long-term health condition: the health literacy pathway model. 
BMC Public Health. 2012;12:130. Published 2012 Feb 14. doi:10.1186/1471-2458-12-130) 
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Exhibit 5. Summary of learnings and Proposed Actions for Collaboration in ToC [73] 
Learnings Proposed Actions 
• Increased empathy towards older people and 
the limitations and difficulties they may face 
during the discharge process; 
• Greater understanding of the multidisciplinary 
team and the roles and difficulties faced by other 
professionals involved in the process of care 
transitions home; 
• The importance of good interprofessional 
collaboration across the professions and the 
sharing of information; 
• The factors that promote a successful care 
transition; 
• The personal and communication skills needed 
for working with older people with complex 
needs. 
• More empathetic approach: establishing a 
relationship with the patient early on and being 
person-centered and sensitive to older people’s 
needs 
• Increased involvement of patients and families 
in planning care transitions 
• Improved communication and interprofessional 
collaboration across the care settings 
• Ensure there is clarity about who is responsible 
for different roles and actions during care 
transitions and ensure that each health 
professional feels valued 
• Be more proactive: anticipate problems and 
have back-up plans 
• Educate colleagues about care transitions home 
e.g. ensure inclusion in junior staff induction 
• Reflect on what has worked in care transitions 
and what could have been improved 
• Apply their increased understanding of consent 
and mental capacity to care transitions 
• Apply their increased awareness of local 
processes for care transitions and 
documentation 
 
Conclusion 
Community pharmacists are among the most 
accessible front-line primary care practitioners 
and are well positioned to affect the care of 
homebound patients. Pharmacist-directed 
home medication reviews offer an effective 
mechanism to address the pharmacotherapy 
issues of those members of the community who 
are most in need but may otherwise lack 
access to pharmacy services. As the general 
population ages, the demand for such services 
will undoubtedly increase. Pharmacist-directed 
home medication reviews could serve to 
minimize inappropriate use of medication, 
maximize health care cost savings and expand 
the scope of pharmacy practice 
Article Summary 
The arrangement of home care has existed 
since the turn of the only remaining century, 
when societal concerns with respect to 
migration, industrialization, and irresistible 
infections brought forth the requirement for 
visiting medical attendants. Early homecare 
services primarily consisted of midwife and 
nursing assistance for births, and the care of 
influenza and tuberculosis patients. This early 
form of home care paved the way for the 
development of alternate site healthcare. In the 
past, the term home care generally referred to 
community-based nursing services provided to 
patients in their homes. Today, the term has 
been expanded to include home/alternate site 
healthcare and encompasses: long-term care, 
and skilled nursing facilities, assisted living and 
subacute facilities, home care, diagnostic 
centers, outpatient clinics, ambulatory surgery, 
rehabilitation facilities, and emergency service 
markets. 
Abbreviations: Medicines Optimization in Care 
Homes (MOCH); Medication-related problems 
(MRPs); Residential Aged Care Home (RACH); 
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Methicillin-resistant Staphylococcus aureus 
(MRSA); American Academy of Family 
Physicians (AAFP); International Association 
for Hospice and Palliative Care (IAHPC); 
Center to Advance Palliative Care (CAPC); 
Patient Centered Care (PCC); Length Of Stay 
(LOS), Length From Admission To Palliative 
Care Consult (LTC), Consult To Discharge Or 
Death (CTD); National Comprehensive Cancer 
Network (NCCN); Pediatric Palliative Care 
(PPC); National Hospice and Palliative Care 
Organization’s (NHPCO); Winnipeg Regional 
Health Authority (WRHA); Pharmacist 
Advancement of Transitions of Care to Home 
(PATCH); Home Medicines Review (HMR); 
Transition of Care (ToC); Chronic obstructive 
pulmonary disease (COPD); Acute 
Exacerbation of COPD (AECOPD); Low Health 
Literacy (LHL); Pharmacist Intervention for Low 
Literacy in Cardiovascular Disease”  (PILL-
CVD); Health-Related Quality of Life (HRQL); 
Heart failure (HF); Frequent Exacerbation 
(FEs); Emphysema Index (EI); Total Hip 
Arthroplasty (THA); Total Knee Arthroplasty 
(TKA), Total Joint Arthroplasty (TJA); 
Potentially Inappropriate Medications (PIM); 
Screening Tool Of Older People’s Prescriptions 
(STOPP) Screening Tool To Alert Doctors To 
Right Treatment (START) 
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